Chronic obstructive pulmonary disease (LCD) is a common, preventable and treatable disease characterized by persistent air flow restrictions and corresponding respiratory symptoms. Antibiotic treatment is a key link in slow-to-pulmonary treatment, but it is important to take the right time for treatment.
For patients with slow lung resistance, the use of antibiotics should be considered when: The first is an increase in symptoms, mainly cough, cough and respiratory difficulties. If the nature of a patient ‘ s sluice changes, for example from white slime to yellow, green pus, this often suggests a possible bacterial infection. Because, under normal circumstances, the sluice of a patient with a slow lung can be white slime, bacteria and the toxins they release cause a change in the sluice colour and texture when bacteria is infected. Moreover, when the amount of cough is significantly increased, it may also be that bacterial infections lead to increased respiratory inflammation and irritation of gaseous mucous membranes to produce more secretions.
The second is the increased respiratory difficulties for patients with slow-retarded lungs. This may be due to the inflammation and oedema caused by the infection, leading to an increase in the narrowness of the gas lanes. After bacterial infections, the body’s immune system is activated and various inflammatory media are released, which can cause air-path smoothing muscles to shrink, mucous membranes to swell, further hinder air flow and make breathing more difficult for patients. This increase in respiratory difficulties cannot be explained solely by an increase in the activity of patients with slow lungs or by other non-infective factors.
In addition, slow-to-heating lung patients are an important signal. The fever is a whole-body reaction to the infection. When bacteria reproduce in the body, the heat is released, stimulating the body temperature-regulating centre of the human body and increasing the body temperature. In general, treatment of antibiotics needs to be taken into account if the temperature of patients with slow lung resistance exceeds 38°C and other non-infective causes of fever, such as high ambient temperatures and self-immunological diseases, are likely to be caused by bacterial infections.
However, other factors need to be taken into account by doctors before patients who slow down their lungs decide to use antibiotics. On the one hand is the patient ‘ s medical history, such as the frequency of infection, the type of pathogen in which the infection occurred. If a patient is frequently infected with a copper-green-false cystasy, then effective drugs for this bacteria need to be considered when choosing antibiotics. On the other hand, the patient ‘ s state of health, including liver and kidney function, etc. Since antibiotics are mostly subject to liver and kidney metabolism, patients with chronic obstructive lung with incomplete liver and kidneys may need to adjust the dose when using antibiotics in order to avoid the toxicity of the drug in the body.
At the same time, microbiological examinations, such as sapling, should be carried out as far as possible in the case of slow-retracting lung patients considering the use of antibiotics for precision treatment. The type of pathogens can be identified through sapling and the most sensitive antibiotics can be selected. This not only enhances the effectiveness of treatment but also avoids the abuse of antibiotics. If empirical treatment with antibiotics is required prior to the results of the examination, appropriate drugs should also be selected based on local bacterial resistance and patient-specific conditions, and the treatment programme should be adjusted in a timely manner when the results are available. Properly managing the time of antibiotic treatment for patients with slow lung resistance is crucial for controlling the condition, reducing complications and improving the quality of life of patients.
